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Influence of bone marrow fat embolism on coagulation
activation in an ovine model of vertebroplasty
Abstract
BACKGROUND: Intraoperative cardiovascular deterioration as a result of pulmonary embolization of
bone marrow fat is a potentially serious complication during vertebroplasty. The release of fatty material
and thromboplastin from the bone marrow cavity during vertebroplasty may activate the coagulation
cascade resulting in thrombogenesis, and pharmacological prophylaxis may therefore prevent
cardiovascular complications. Thus, the effects of bone marrow fat embolism on coagulation activation
during vertebroplasty were investigated with use of an animal model. METHODS:
Polymethylmethacrylate was injected into three lumbar vertebrae of six sheep in order to force bone
marrow fat into the circulation. Invasive blood pressures and heart rate were recorded continuously until
sixty minutes after the last injection. Cardiac output, arterial and mixed venous blood gas parameters,
and coagulation parameters were measured at selected time-points. Postmortem lung biopsy specimens
were assessed for the presence of intravascular fat. RESULTS: Embolization of bone marrow fat
resulted in a sudden and dramatic increase in mean pulmonary arterial pressure and a decrease in mean
arterial blood pressure. There were no significant changes in any coagulation parameter from before the
injection to after the injection. Intravascular fat and bone marrow cells were present in all lung lobes.
CONCLUSIONS: Injection of polymethylmethacrylate into vertebral bodies caused embolization of
bone marrow fat with subsequent transient cardiovascular deterioration, but no changes in coagulation
parameters were observed. Thromboembolism did not contribute to the observed cardiovascular
changes.
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Influence of Bone Marrow Fat Embolism
on Coagulation Activation in an Ovine
Model of Vertebroplasty
By Jo¨rg Krebs, DVM, PhD, Stephen J. Ferguson, PhD, PD, Simon P. Hoerstrup, MD, Ben G. Goss, PhD,
Andre´ Haeberli, PhD, and Nikolaus Aebli, MD, PhD
Investigation performed at the MEM Research Center, Institute for Surgical Technology and Biomechanics,
Medical Faculty, University of Bern, Bern, Switzerland
Background: Intraoperative cardiovascular deterioration as a result of pulmonary embolization of bone marrow fat is a
potentially serious complication during vertebroplasty. The release of fatty material and thromboplastin from the bone
marrow cavity during vertebroplasty may activate the coagulation cascade resulting in thrombogenesis, and pharma-
cological prophylaxis may therefore prevent cardiovascular complications. Thus, the effects of bonemarrow fat embolism
on coagulation activation during vertebroplasty were investigated with use of an animal model.
Methods: Polymethylmethacrylate was injected into three lumbar vertebrae of six sheep in order to force bone marrow
fat into the circulation. Invasive blood pressures and heart rate were recorded continuously until sixty minutes after the
last injection. Cardiac output, arterial and mixed venous blood gas parameters, and coagulation parameters were mea-
sured at selected time-points. Postmortem lung biopsy specimens were assessed for the presence of intravascular fat.
Results: Embolization of bone marrow fat resulted in a sudden and dramatic increase in mean pulmonary arterial
pressure and a decrease in mean arterial blood pressure. There were no significant changes in any coagulation parameter
from before the injection to after the injection. Intravascular fat and bone marrow cells were present in all lung lobes.
Conclusions: Injection of polymethylmethacrylate into vertebral bodies caused embolization of bone marrow fat with
subsequent transient cardiovascular deterioration, but no changes in coagulation parameters were observed. Throm-
boembolism did not contribute to the observed cardiovascular changes.
Clinical Relevance: Cardiovascular complications as a result of bone marrow fat embolism should be considered in
patients undergoing vertebroplasty. Vertebroplasty with use of polymethylmethacrylate does not appear to activate the
coagulation system or cause thromboembolism.
I
ntraoperative cardiovascular deterioration is a potentially
serious complication during vertebroplasty. Pulmonary
cement embolism is a reason for cardiovascular compli-
cations during vertebroplasty1,2. But cardiovascular changes,
such as arterial hypotension, oxygen desaturation, and ar-
rhythmia, have also been observed in the absence of cement
embolism and have been attributed to bone marrow fat em-
bolization3-6. Cardiovascular changes resulting from fat em-
bolism are often transient, but may be fulminant, resulting in
cardiac arrest and even death6-9. Aebli et al.10 demonstrated the
embolization of bone marrow fat during vertebroplasty in an
animal model, using transesophageal echocardiography and
histopathology of the lungs. Associated cardiovascular deteri-
oration was characterized by transient but severe pulmonary
hypertension, arterial hypotension, decreased cardiac output,
and respiratory acidosis in this animal model11.
Fat embolism is a well-known complication during total
hip and knee arthroplasty12-15, intramedullary reaming16,17, and
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excess of $10,000 from the Wesley Foundation, Brisbane, Australia; the AO Foundation, Davos, Switzerland; and AOSpine, Du¨bendorf, Switzerland (SRN
02/105). Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such
benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation,
division, center, clinical practice, or other charitable or nonprofit organization with which the authors, or a member of their immediate families, are
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instrumented spine surgery18,19. Reducing the severity of fat
embolism by 50% did not result in clinically relevant allevia-
tion of cardiovascular deterioration during vertebroplasty in
an animal model20. Activation of the coagulation cascade may
have resulted in an additional embolic burden rendering the
reduction of fat emboli ineffective. It has been suggested that
the release of fat emboli and thromboplastin from the bone
marrow cavity during hip arthroplasty may result in throm-
bogenesis21-23. Furthermore, polymethylmethacrylate may have
inherent thrombogenic properties24,25. Activation of the coag-
ulation cascade may therefore play a role in the development of
cardiovascular changes during vertebroplasty. Pharmacological
prophylaxis of thrombogenesis in patients undergoing verte-
broplasty may therefore be useful for preventing cardiovascular
complications. Thus, the effects of bone marrow fat embolism
and the injection of polymethylmethacrylate into vertebral
bodies on coagulation activation were investigated with use of
an animal model.
Materials and Methods
Animal Model
Investigations were carried out in six skeletally maturemixed-bred ewes (five to six years old with a mean body
weight [and standard deviation] of 70 ± 10 kg), which were
subjected to unilateral augmentation of three lumbar vertebral
bodies (L2-L4) with polymethylmethacrylate. The study was
approved by the State Animal Ethics Committee and was
conducted according to federal and state guidelines.
Instrumentation of Animals
Anesthesia was induced with propofol (6 mg/kg) and was
maintained with isoflurane (2% to 3%) in oxygen (50%).
Analgesia and muscle relaxation were achieved by the admin-
istration of buprenorphine (0.005 mg/kg) and pancuronium
(0.06 mg/kg), respectively. The lungs were ventilated me-
chanically to maintain physiologic end-tidal carbon dioxide
tension prior to cement injection. End-tidal carbon dioxide
tension was measured with an infrared capnometer. Ventilation
parameters were not adjusted after cement injection. Lactated
Ringer solution was infused through the left cephalic vein at 4
mL/kg/h. Electrocardiographic monitoring was obtained with
skin electrodes.
For cardiovascular instrumentation, animals were placed
in the supine recumbent position. An angiography catheter
was inserted into the left carotid artery and was advanced into
the left ventricle to measure blood pressure. The right carotid
artery was cannulated to measure arterial blood pressure and
to obtain blood samples. A Swan-Ganz thermodilution pul-
monary artery catheter was inserted into the right jugular vein
and was floated into the pulmonary artery to measure central
venous pressure, pulmonary arterial pressure, and cardiac out-
put and to obtain mixed venous blood samples. The correct
position of the ventricular and pulmonary catheters was con-
firmed by recording typical pressure waves. Catheters were con-
nected to pressure transducers (Uniflow; Baxter, Volketswil,
Switzerland) by means of pressure tubing filled with liquid
(Ringer lactate solution). Catheters were flushed with hepa-
rinized Ringer lactate solution (5000 IU/L) after insertion and
after taking blood samples. Injected volumes were approxi-
mately 15 mL/h and deemed not to affect hemostasis26. Heart
rate was derived from the electrocardiogram. Cardiovascular
pressures and the electrocardiographic recordings were digi-
tized at 1 Hz with use of an analog-digital converter (Hellige
Messturm; Marquette Hellige Medizintechnik, Freiburg, Ger-
many) and stored on a computer for offline analysis.
Surgical Procedure and Cement Injections
Animals were placed in the right lateral recumbent position on
the operating table. A retroperitoneal approach was used to
expose the lateral aspect of three lumbar vertebral bodies (L2-
L4). A cement injection hole (3.5 mm in diameter) was drilled
into the cephalad aspect of each vertebral body to a depth of
10.0 mm. The proximal part of the injection hole was carefully
widened to a diameter of approximately 4.0 mm, so that the tip
of a 3-mL syringe would fit tightly into it.
Polymethylmethacrylate bone cement formulated for
vertebroplasty (low viscosity, 30% barium) (Mendec; Tecres
Medical, Verona, Italy) was used for injection. Powder and
chilled liquid (5C) were mixed in an open bowl for thirty
seconds and then drawn into 3-mL polycarbonate syringes
(Medicor, Cham, Switzerland). The cement was left to po-
lymerize at room temperature (21 to 23C; 27% to 34% hu-
midity) until an appropriate viscosity for injectionwas reached.
A volume of 6.0 mL of cement was injected over thirty seconds
until filling of the vertebral body was achieved.
Experimental Protocol
Pressure transducers were zeroed at the level of the heart.
Blood pressures and electrocardiographic activity were con-
tinuously recorded until sixty minutes after beginning the last
(i.e., third) cement injection. Cardiac output and blood gas
parameters were measured before and at least twenty minutes
after completion of the surgical approach. Cardiac output was
measured three times and averaged. Arterial and mixed venous
blood samples were drawn for blood gas analysis, which was
carried out immediately. Cement was injected into three
lumbar vertebrae (L2-L4) after a twenty-minute time-interval
between injections. The duration of the time-intervals was
sufficient for stabilization of cardiovascular parameters to a
new steady state10,11. Postinjection evaluation of cardiac output
and blood gas parameters was carried out one minute and ten
minutes after having started the first injection; ten minutes
after having started the second injection; and ten minutes,
thirty minutes, and sixty minutes after having started the third
injection. At the end of the protocol, the animals were killed by
intravenous injection of pentobarbital (1 g/sheep) and potas-
sium chloride (2 mmol/kg).
Analysis of Cardiovascular Data
In order to obtain preinjection values of continuously recorded
parameters (i.e., blood pressures and heart rate), data were
averaged over five minutes. For postinjection values, data were
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averaged over twenty seconds. Cardiac index, pulmonary vas-
cular resistance index, systemic vascular resistance index, phys-
iologic dead space, and intrapulmonary shunt were calculated
with use of standard formulas.
Measurements of Coagulation Parameters
Citrated blood samples were taken prior to induction of an-
esthesia (jugular vein) and prior to the first cement injection
(i.e., after instrumentation and surgical approach) (carotid
artery). Further samples (carotid artery) were taken one min-
ute and ten minutes after having started the first injection; ten
minutes after having started the second injection; and ten
minutes, thirty minutes, and sixty minutes after having started
the third injection. Blood samples were centrifuged immedi-
ately after sampling, and the plasma was stored at –70C for
batch analysis. The following parameters were measured:
thrombocyte count, prothrombin time, partial thromboplastin
time, fibrinogen, D-dimer, and thrombin-antithrombin com-
plexes. Analyses were performed in two certified laboratories
with use of standard protocols. A given parameter was always
measured in the same laboratory.
Histopathology
After the animals were killed, two lung tissue samples were
taken from two predetermined areas of each of the five lung
lobes (right cranial, middle, and caudal lobes and left cranial
and caudal lobes) and were fixed in 10% neutral buffered
formalin. Specimens were stained with hematoxylin and eosin
and oil red O (fat stain). Two microscopic views (at five times
magnification) were analyzed from each sample for the
TABLE I Cardiovascular Parameters Measured Continuously*
Before Injection
(N = 17)
1 Min
(N = 17)
3 Min
(N = 17)
5 Min
(N = 17)
10 Min
(N = 17)
15 Min
(N = 17)
30 Min
(N = 6)
60 Min
(N = 6)
Mean arterial blood pressure (mm Hg) 86 ± 10 68 ± 24† 93 ± 18 95 ± 14 88 ± 11 82 ± 12 78 ± 15 81 ± 10
Mean pulmonary arterial pressure (mm Hg) 19 ± 3 36 ± 6‡ 29 ± 4‡ 26 ± 3‡ 22 ± 2 20 ± 3 21 ± 2 21 ± 3
Mean central venous pressure (mm Hg) 8 ± 3 11 ± 4† 9 ± 2 9 ± 3 9 ± 2 8 ± 2 9 ± 2 9 ± 3
Heart rate (bpm) 89 ± 12 93 ± 17 91 ± 13 88 ± 13 88 ± 12 88 ± 12 89 ± 20 79 ± 8
*The values are given as the mean and the standard deviation. †Significantly different from preinjection value (p < 0.004). ‡Significantly different
from preinjection value (p < 0.0000).
TABLE II Cardiovascular Parameters Measured Periodically*
Before
Injection
(N = 6)
1 Min After
First Cement
Injection
(N = 6)
10 Min After
First Cement
Injection
(N = 6)
10 Min After
Second Cement
Injection
(N = 5)
10 Min After
Third Cement
Injection
(N = 6)
30 Min After
Third Cement
Injection
(N = 6)
60 Min After
Third Cement
Injection
(N = 6)
Cardiac index (L/min/m2) 4.9 ± 0.8 4.6 ± 1.1 5.0 ± 0.7 4.6 ± 1.6 4.5 ± 1.7 4.4 ± 1.6 4.4 ± 1.3
Pulmonary vascular
resistance index
(dyne d s/cm5/m2)
246 ± 99 644 ± 203† 283 ± 84 354 ± 97 348 ± 152 340 ± 141 317 ± 122
Systemic vascular
resistance index
(dyne d s/cm5/m2)
1208 ± 184 1124 ± 408 1198 ± 130 1412 ± 330 1405 ± 360 1237 ± 303 1327 ± 322
pH 7.48 ± 0.03 7.46 ± 0.03 7.47 ± 0.03 7.47 ± 0.02 7.46 ± 0.02 7.47 ± 0.02 7.47 ± 0.02
Arterial carbon dioxide
tension (kPa)
5.2 ± 0.4 5.6 ± 0.3 5.3 ± 0.4 5.3 ± 0.4 5.4 ± 0.5 5.3 ± 0.2 5.4 ± 0.5
Arterial oxygen
tension (kPa)
36 ± 14 36 ± 13 36 ± 13 35 ± 15 36 ± 16 35 ± 16 37 ± 18
Dead space (Vd/Vt)‡ 0.12 ± 0.07 0.20 ± 0.04† 0.12 ± 0.07 0.13 ± 0.09 0.16 ± 0.08 0.16 ± 0.05 0.16 ± 0.06
Intrapulmonary
shunt (Qs/Qt)§
0.015 ± 0.006 0.015 ± 0.003 0.015 ± 0.003 0.017 ± 0.004 0.016 ± 0.004 0.018 ± 0.005 0.015 ± 0.005
*The values are given as the mean and the standard deviation. †Compared with the value before the first injection value, the difference was
significant (p < 0.02). ‡Vd/Vt = ratio of physiologic dead space to tidal volume. §Qs = shunt flow, and Qt = cardiac output.
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presence of intravascular fat and bone marrow cells. Semi-
quantitative analysis of intravascular fat was performed by
counting the number of emboli in each photomicrograph.
Counts were averaged and presented as a histopathologic
score.
Statistical Analysis
According to data from previous studies10,20, the chosen sample
size was sufficient to detect clinically relevant changes of blood
pressure and blood gas variables from preinjection and post-
injection values with the power ranging from 88% to 97%.
Data were calculated and given as the mean and the standard
deviation of the mean. One-way analysis of variance for re-
peated measures was used to test for significant differences.
Post hoc analyses were performed with use of the Bonferroni
test. The paired Student t test was used to test for differences in
histopathologic scores between the different lung lobes. A p
value of £0.05 was considered significant for all statistical
Fig. 1
Mean pulmonary arterial pressure and mean arterial blood pressure after polymethylmethacrylate
injection (pooled data). An asterisk indicates a significant difference from preinjection value
(p < 0.02).
TABLE III Coagulation Parameters Before and After Embolization*
Before
Induction of
Anesthesia
Before First
Cement
Injection
1 Min
After First
Injection
10 Min
After First
Injection
10 Min
After Second
Injection
10 Min
After Third
Injection
30 Min
After Third
Injection
60 Min
After Third
Injection
Thrombocytes
(103/mL)
315 ± 126
(6)
197 ± 54†
(6)
223 ± 44†
(6)
215 ± 48†
(6)
204 ± 49†
(6)
202 ± 42†
(6)
198 ± 44†
(6)
206 ± 46†
(6)
Prothrombin time (%) 80 ± 5 (5) 74 ± 9 (6) 73 ± 8 (6) 74 ± 8 (6) 72 ± 10 (6) 73 ± 10 (6) 69 ± 9 (5) 68 ± 7 (5)
Partial thromboplastin
time (sec)
31 ± 3 (5) 31 ± 4 (6) 30 ± 4 (6) 31 ± 3 (6) 29 ± 4 (5) 30 ± 5 (6) 32 ± 4 (5) 31 ± 4 (5)
Fibrinogen (g/L) 2.1 ± 0.5 (5) 1.6 ± 0.4 (6) 1.6 ± 0.4 (5) 1.5 ± 0.4 (6) 1.6 ± 0.4 (5) 1.6 ± 0.3 (5) 1.5 ± 0.3 (4) 1.5 ± 0.3 (4)
D-dimer (mg/L) 1.2 ± 1.3 (5) 0.9 ± 0.9 (6) 0.9 ± 0.9 (6) 0.9 ± 0.9 (6) 0.9 ± 0.9 (6) 0.9 ± 0.9 (6) 1.0 ± 1.0 (5) 1.0 ± 1.0 (5)
Thrombin-antithrombin
complexes (mg/L)
1.16 ± 0.21
(5)
3.01 ± 0.75‡
(6)
4.26 ± 1.29‡
(6)
3.37 ± 0.82‡
(5)
4.03 ± 0.63‡
(4)
4.02 ± 0.75‡
(5)
4.28 ± 1.46‡
(4)
4.50 ± 1.28‡
(5)
*The values are given as the mean and the standard deviation, with the number of samples in parentheses. †Compared with value before induction of anesthesia,
the difference is significant (p < 0.003). ‡Compared with value before induction of anesthesia, the difference is significant (p < 0.05).
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analyses. Statistical analyses were performed with use of Sta-
tistica 7 software (StatSoft, Hamburg, Germany).
Results
Cement Injections
On the average, 4.7 ± 0.7 mL of polymethylmethacrylatewas injected into each vertebral body over an average of
31 ± 11 sec. One injection was judged inadequate because
insufficient cement volume had been injected (i.e., <3 mL). In
that case, the cement viscosity had been too high to inject more
volume. Cardiovascular data from this injection were excluded
from analysis. At the postmortem examination, cement leak-
age into epidural and paravertebral veins was discovered in
two animals.
Cardiovascular Parameters
There were no significant (p = 0.71) differences among the
cardiovascular changes after the three cement injections and
among the three preinjection values (p = 0.98). Injections of
polymethylmethacrylate elicited a consistent cardiovascular
response after each injection. Thus, the data of the continu-
ously recorded parameters (i.e., invasive pressures and heart
rate) from the three embolization events were pooled, and
statistical analysis was performed.
Injection of polymethylmethacrylate elicited a significant
(p < 0.0001) increase in the mean pulmonary vascular resis-
tance index (150% ± 53%) and the mean pulmonary arterial
pressure (108% ± 32%) (Tables I and II). Consequently, there
was a significant (p < 0.004) decrease in the mean arterial
blood pressure (36% ± 16%) and a significant (p < 0.004) in-
crease in the mean central venous blood pressure (54% ±
29%). Values of mean arterial blood pressure and central
venous blood pressure were no longer significantly (p > 0.9)
different from preinjection values two minutes after induc-
ing fat embolization. The mean pulmonary arterial pressure
remained elevated until nine minutes after embolization
(Fig. 1).
Coagulation Parameters
There was a significant (p < 0.05) decrease in thrombocyte
count and a significant increase in the concentration of
thrombin-antithrombin complexes from the preanesthetic to
preinjection values (Table III). The mean plasma concentra-
tions of thrombin-antithrombin complexes increased from the
value before the injection (3.01 ± 0.75 mg/L) to one minute
after the injection (4.26 ± 1.29 mg/L), and the mean pro-
thrombin time decreased from the value before the injection
(74% ± 9%) to sixty minutes after the injection (68% ± 7%).
However, these changes were not significant (p > 0.3). There
were no other changes in coagulation parameters from pre-
injection to postinjection values.
Histopathology
Intravascular fat and bone marrow cells were present in all lung
lobes (Fig. 2). The mean histopathologic score for all five lobes
(thirty specimens) was 4.9 ± 3.7. There were no significant
(p = 0.16) differences in the histopathologic scores among the
different lung lobes. Traces of intravascular bone cement (i.e.,
Fig. 2
Photomicrograph showing intravascular fat (asterisks) and bone marrow cells (arrows) in the lungs
(hematoxylin and eosin). The bar represents 100 mm.
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barium particles) were detected in two lung lobes. Cardio-
vascular responses recorded in these animals were not signif-
icantly (p = 0.9) different from responses in animals without
pulmonary cement embolism.
Discussion
The cardiovascular response to bone marrow fat embolismafter intravertebral injection of polymethylmethacrylate
was characterized by a sudden (one minute postinjection) and
dramatic (>100%) increase in mean pulmonary arterial pres-
sure and a decrease in mean arterial blood pressure (36%).
There were no significant changes in any coagulation param-
eter from preinjection to postinjection values.
In the present study, fat embolization during verte-
broplasty in sheep with use of polymethylmethacrylate did not
affect any of the measured coagulation parameters. In contrast,
Barie and Malik27 observed a decrease in fibrinogen and an
increase in fibrin degradation products after an intravenous
injection of allogenic bone marrow suspension in sheep. De-
fibrinogenation completely prevented any cardiovascular changes.
Fibrinogen depletion prevented thrombogenesis and therefore
the blockage of the pulmonary vasculature. The process of
harvesting bone marrow may have activated the coagulation
cascade in their study. However, the present model mimics the
clinical situation more closely.
Thrombogenesis has also been observed after arthro-
plasty and long-bone intramedullary reaming. These inter-
ventions cause more vascular and tissue damage compared
with the injection of polymethylmethacrylate into vertebral
bodies. An increase in thrombin-antithrombin complex con-
centration and changes in antithrombin and fibrinogen values
were observed after reaming of the femoral medullary cavity
for hip arthroplasty24 and intramedullary nailing28, respectively.
Modig et al.22 investigated the role of coagulation, fat embo-
lism, and methylmethacrylate in the development of arterial
hypotension and hypoxemia during total hip arthroplasty with
cement. Activation of the coagulation cascade was observed
immediately after the insertion of the femoral component. The
recorded cardiovascular changes were correlated with the degree
of coagulation activation, but not with the severity of fat em-
bolization or the plasma concentrations of methylmethacrylate.
More recently, coagulation activation during total hip arthro-
plasty with and without cement was demonstrated by an increase
in thrombin-antithrombin complex and D-dimer values23.
It has been suggested that coagulation may be activated
by cell fragments released from the bone marrow cavity22 or
thromboplastin (protease, which converts prothrombin to
thrombin)22,29. Thromboplastin may be released from adipose
bone marrow tissue29 or as a result of subendothelial tissue
damage in the bone marrow cavity 28 or in the lungs27. Fur-
thermore, polymethylmethacrylate may have inherent throm-
bogenic properties24,25. Serious concerns have been raised with
regard to the use of calcium phosphate cement for vertebro-
plasty as it may aggravate cardiovascular complications by
stimulating coagulation30. Calcium phosphate cement may
provide a scaffold for clot formation or may initiate the co-
agulation cascade by surface contact activation and providing
calcium ions, an important cofactor for coagulation. However,
more recent studies have found no coagulation activation
after both polymethylmethacrylate and calcium phosphate
cement came in contact with circulating blood in vitro31 and
in vivo32,33.
Quantification of thrombin-antithrombin complexes
allows one to detect subtle degrees of coagulation activation.
The key event of coagulation activation is the conversion of
prothrombin to thrombin. However, only a small amount of
circulating prothrombin (<1%) is activated to thrombin, and
thrombin is rapidly neutralized by antithrombin, resulting in
an increase in circulating thrombin-antithrombin complexes.
In the present study, there was a significant increase in the
concentration of thrombin-antithrombin complexes and a
significant decrease in the thrombocyte count from the pre-
anesthetic to preinjection values. This may have been the result
of the instrumentation and the surgical approach to the lum-
bar spine. There was no significant change in thrombin-anti-
thrombin complex or any other coagulation parameter from
preinjection to postinjection values. Recording was terminated
sixty minutes after the last embolization event, and coagu-
lopathy may occur later on as a result of lung injury or blood
flow disturbances34. However, the focus of the present study
was on the intraoperative cardiovascular changes after bone
marrow fat embolism.
Activation of the coagulation cascade generating addi-
tional emboli did not contribute to the acute cardiovascular
changes after fat embolism elicited by injections of poly-
methylmethacrylate into vertebral bodies. However, blockage
of >50% of the pulmonary arterial vasculature would be re-
quired to elicit cardiovascular changes of the magnitude re-
corded in the present study35,36. Blockage of this magnitude is
improbable according to the histopathologic results and data
reported in the literature10,29,37, and thus mechanical blockage
would not seem to be responsible for the recorded cardio-
vascular changes in the present study. The increase in pul-
monary arterial pressure may have been caused by pulmonary
vasoconstriction elicited by vasoactive mediators released from
the bone marrow cavity or as a result of lung injury after
embolization38,39. Alternatively, a reflex response to emboliza-
tion may have elicited pulmonary vasoconstriction40,41. Meth-
ylmethacrylate has also been reported to cause pulmonary
vasoconstriction42,43. However, concentrations of methylmeth-
acrylate required to elicit cardiovascular changes are more than
twice as high as concentrations measured clinically44,45.
It has been suggested that kyphoplasty may carry a lower
risk of fat embolism compared with vertebroplasty. Kypho-
plasty is only performed in vertebral bodies with acute (i.e.,
mobile) fractures, and fracture lines may offer a way of pres-
sure release and escape for the fat emboli during inflation of
the balloon. Potentially beneficial effects are therefore a result
of the different indications (only acute compared with acute
and old fractures) and are not inherent to the type of inter-
vention (i.e., kyphoplasty compared with vertebroplasty).
Vertebroplasty of unconsolidated or highly compressed ver-
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tebral bodies also carries a low risk of fat embolism. On the
other hand, augmentation of intact osteoporotic vertebral
bodies at risk of fracture may carry a high risk of fat embolism.
Limitations of the present animal model have been dis-
cussed previously10,11. Briefly, vertebral filling was higher com-
pared with the clinical situation. However, it was crucial to
inject similar volumes of cement compared with the clinical
situation, displacing similar volumes of bone marrow fat. The
aim of the present study was to investigate the pathophysiology
of cardiovascular changes after bone marrow fat embolism,
rather than replicating clinical vertebroplasty. Flushing cath-
eters with heparinized Ringer solution may have affected
measured coagulation parameters. The prothrombin time de-
creased by 8% from before anesthesia to before injection and
again by 7% and 8% from before injection to thirty and sixty
minutes after injection, respectively. There was a 15% decrease
from before anesthesia to sixty minutes after injection. How-
ever, these changes were not significant, and, moreover, there
were no changes in partial thromboplastin time. Therefore,
injected volumes of heparin appeared to be insufficient to af-
fect measured coagulation parameters.
In conclusion, injection of polymethylmethacrylate into
vertebral bodies elicited embolization of bone marrow fat with
subsequent transient cardiovascular deterioration. Thrombo-
embolism did not contribute to the observed cardiovascular
changes. Cardiovascular complications as a result of bone mar-
row fat embolism should be considered in patients undergoing
vertebroplasty. n
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